PROFILE

ƒOƒ‹[ƒv‰ïŽÐ

ƒ}[ƒPƒeƒBƒ“ƒOŽ–‹Æ‰ïŽÐ

Š”Ž®‰ïŽÐTARGET“à TheJapanProjectŽ–‹Æ•”

“Œ‹ž“sç‘ã“c‹æˆê”Ô’¬9-23 ˆê”Ô’¬ƒrƒ‹ The Platform

ƒRƒ“ƒTƒ‹ƒeƒBƒ“ƒOŽ–‹Æ‰ïŽÐ

Š”Ž®‰ïŽÐTARGETioŽ‘”ä—¦90%j

“Œ‹ž“sç‘ã“c‹æˆê”Ô’¬9|23 ˆê”Ô’¬ƒrƒ‹ The Platform

ŠCŠOioŽx‰‡Ž–‹Æ‰ïŽÐ

GX Overseas Limited.

`àsŽeŒ¬“òŽ“¹302]308 W¬’†S20žê2008Žº

Œš’zƒfƒUƒCƒ“E‹óŠÔƒvƒƒfƒ…[ƒXŽ–‹Æ‰ïŽÐ

Š”Ž®‰ïŽÐ56ÝŒvŽÉ

“Œ‹ž“sŽsã‹ž‹æ–û¬˜H’Ê’†—§”„‰ºƒ‹b”ãŽç’¬97@¼wŽY‹Æ‘n‘¢˜ðŠÚ8†Žº

ƒAƒpƒŒƒ‹Ž–‹Æ‰ïŽÐ

Š”Ž®‰ïŽÐƒ^ƒCƒOƒŠƒX

§171-0031@“Œ‹ž“s–L“‡‹æ–Ú”’3-5-13

ˆã—ÁEiPS×–EŒ¤‹†‰ïŽÐ

Š”Ž®‰ïŽÐ_ŒËˆã—ÓÁ‹æ“à One Medicine,One HealthƒZƒ“ƒ^[

§650-0046@•ºŒÉŒ§_ŒËŽs’†‰›‹æ`“‡’†’¬Žl’š–Ú1”Ô1†@ƒ|[ƒgƒAƒCƒ‰ƒ“ƒhƒrƒ‹11ŠK

“®•¨•a‰@‰^‰cŽ–‹Æ‰ïŽÐ

Š”Ž®‰ïŽÐƒGƒ‹ƒ€ƒXƒ†ƒiƒCƒeƒbƒh“®•¨•a‰@ƒOƒ‹[ƒv

§168-0074@“Œ‹ž“s™•À‹æã‚ˆäŒË1-14-4